Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank100
3Y CAGR+6.6%
5Y CAGR+1.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+6.6%/yr
vs -2.2%/yr prior
5Y CAGR
+1.4%/yr
Recent acceleration
Acceleration
+8.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$37.54M+4.5%
2024$35.92M+0.3%
2023$35.82M+15.6%
2022$30.98M-16.8%
2021$37.25M+6.4%
2020$34.99M-3.7%
2019$36.34M+7.5%
2018$33.81M+71.3%
2017$19.74M+48.7%
2016$13.27M-